Could a tailored dialysis schedule be safer for kidney patients?

NCT ID NCT05828823

Recruiting now Disease control Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This study tests whether a personalized, gradual start to dialysis is safer and improves quality of life compared to the standard fixed schedule. It involves 350 adults with end-stage kidney disease who recently started dialysis. Researchers will track hospital visits, overall health, and well-being over two years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

END STAGE KIDNEY DISEASE

Contacts and locations

Locations

Atrium Health Wake Forest Baptist
RECRUITING

Winston-Salem, North Carolina, 27157, United States
Emory University
RECRUITING

Atlanta, Georgia, 30322, United States
Johns Hopkins University School of Medicine (JHUSM)
RECRUITING

Baltimore, Maryland, 21218, United States
Massachusetts General Hospital
RECRUITING

Boston, Massachusetts, 02114, United States
Northwell Health
RECRUITING

Queens, New York, 11427, United States
Renal Research Institute (RRI)
RECRUITING

New York, New York, 10065, United States
University of Florida
RECRUITING

Jacksonville, Florida, 32209, United States
University of Mississippi Medical Center
RECRUITING

Jackson, Mississippi, 39216, United States
University of North Carolina Chapel Hill
RECRUITING

Chapel Hill, North Carolina, 27599, United States
University of Virginia (UVA)
RECRUITING

Charlottesville, Virginia, 22904, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.